title: Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis.
authors.forename: A M
authors.initials: AM
authors.lastname: Ortiz García
authors.forename: I
authors.initials: I
authors.lastname: González-Alvaro
authors.forename: R
authors.initials: R
authors.lastname: Roselló Pardo
authors.forename: L
authors.initials: L
authors.lastname: Carmona
authors.forename: M D
authors.initials: MD
authors.lastname: Fábregas Canales
authors.forename: I
authors.initials: I
authors.lastname: Monteagudo Saez
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001168:Arthritis / Q000188:drug therapy*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000069285:Infliximab; D007555:Isoxazoles / Q000008:administration & dosage* / Q000009:adverse effects; D000077339:Leflunomide
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000069285:Infliximab; D000077339:Leflunomide